Front Row Advisors LLC Zoetis Inc. Transaction History
Front Row Advisors LLC
- $282 Million
- Q2 2024
A detailed history of Front Row Advisors LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Front Row Advisors LLC holds 99 shares of ZTS stock, worth $18,807. This represents 0.01% of its overall portfolio holdings.
Number of Shares
99
Previous 99
-0.0%
Holding current value
$18,807
Previous $16,000
6.25%
% of portfolio
0.01%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding ZTS
# of Institutions
1,897Shares Held
423MCall Options Held
1.15MPut Options Held
1.2M-
Vanguard Group Inc Valley Forge, PA41.2MShares$7.83 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$7 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.7MShares$3.74 Billion0.15% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16.2MShares$3.07 Billion2.53% of portfolio
-
Bank Of America Corp Charlotte, NC15.1MShares$2.87 Billion0.23% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $88.9B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...